Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03344
Species: Homo sapiens
Position : chr6:163826086-163833600
Year: 2019
Title: YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  30760518
MONDO: MONDO:0007256
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: PLC/PRF/5
CVCL ID: CVCL_0485
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay; In vivo functional validation
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot; In vivo phenotyping
About Target Gene
Target gene : QKI
About TF
TF name : YY1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
YY1 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
YY1 DNA Damage Recognition in GG-NER reactome 38
YY1 E2F transcription factor network pid 77
YY1 mTOR signaling pathway pid 66
YY1 Notch-mediated HES/HEY network pid 48
YY1 Notch netpath 76
YY1 Notch signaling pathway pid 58
YY1 p53 pathway pid 59
YY1 Signaling events mediated by HDAC Class I pid 89
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer